See every side of every news story
Published loading...Updated

Covalon Technologies earns fourth-straight quarterly profit

Summary by themarketonline.ca
Covalon Technologies (TSXV:COV), a medical technology stock, posted a profitable fiscal Q1 2025 ending December 31, 2024 The company has generated positive net income in each of the past four quarters Covalon is a leading medical technology stock improving patient outcomes in wound care, vascular access and surgical consumables Covalon Technologies stock has added 118.32 per cent year-over-year but only 91.95 per cent since 2020 Covalon Technolo…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

themarketonline.ca broke the news in on Friday, February 21, 2025.
Sources are mostly out of (0)